The promising potential of GNPs in the treatment of various inflammatory and autoimmune disorders led to further interest in examining antioxidant, anti-inflammatory, and anti-hyperglycemic activity accompanied by their capability for extending the duration of insulin action in treating diabetes mellitus. This evidence concerns the gene INS and diabetes mellitus.